Clinical trial
Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy
NCT00329381
Study timeline
Study start (unknown)2006-05-01Date precision: month
Registry last updated2008-06-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Asthmaunresolved
Interventions
XolairDRUG · verified · RxNorm: Xolair
XolairDRUG · verified · RxNorm: Xolair
Sponsors & collaborators
University of Mississippi Medical Centerlead sponsor
Novartiscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00329381 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.